baber/WOPTO huggingface dataset:
Patent DE-69506124-D1 (DE)
Inventor: FERRONATO SANDRO GIOVANNI G
IPC: B24D18/00
Filed: 1995-08-02
Granted: 1998-12-24
Abstract: An adhesive article which has an adhesion of a metal sediment to a carrier material which is stronger than that adhesion which is obtained in the abrasive articles disclosed according to the prior art, which abrasive article comprises a multiplicity of metal sediments which are located some distance apart and are bound to a carrier material, abrasives being embedded in said metal sediments or adhering to the top surfaces of said metal sediments, said metal sediments being obtained via a known electroplating technique, wherein a layer of binder is applied to one side of the carrier material such that said layer of binder extends continuously in cavities which have been formed in the metal sediment from the side where the carrier material is located, and wherein the binder can be a plastic.
Patent DE-69511436-D1 (DE)
Inventor: RASENBERG JOHANNES MARIE
IPC: B60N2/42
Filed: 1995-11-22
Granted: 1999-09-16
Abstract: The invention relates to a vehicle seat, provided with a seat part, a seat back connected thereto on one side and means connected to the seat part for fixing thereof to a vehicle floor, as well as means for controlling a relative movement of the seat back and the seat part under an impact load. These movement control means may comprise carriage elements slidable in the direction of movement of the vehicle and connecting the floor and the fixing means. The movement control means may also comprise means arranged between the seat back and the seat part for slidable connecting thereof in the direction of movement of the vehicle, for instance in the shape of a construction element which is simply plastically deformable under the impact load.
Patent DE-69516116-D1 (DE)
Inventor: SIBSON DAVID ROSS
IPC: C12Q1/6869
Filed: 1995-01-20
Granted: 2000-05-11
Abstract: The present invention provides a method of sequencing a nucleic acid, comprising either sequentially removing bases from the sequence of the nucleic acid a predetermined number at a time, with the product remaining from each step of predetermined base removal being ligated to a labeled adapter specific for said bases and including oligonucleotide sequence, or hybridizing a primer to the nucleic acid to be sequenced and sequentially extending said primer a predetermined number of bases at a time, said added base(s) being complementary to base(s) in the nucleic acid being sequenced, and each of said base addition steps being achieved by the use of a labeled adaptor specific for said bases and including oligonucleotide sequence containing said predetermined base(s); in either case, the label of said labeled adaptor being specific for its respective predetermined base(s).
Patent DE-69517182-D1 (DE)
Inventor: KOHNO SATORU
IPC: C07C17/389
Filed: 1995-07-25
Granted: 2000-06-29
Abstract: The purification of pentafluoroethane (HFC-125) which is composed of a process A, in which an unpurified mixture (1), containing at least chloropentafluoroethane (CFC-115) and pentafluoroethane (HFC-125) is reacted with hydrogen (4) in the presence of a catalyst in gas phase to reduce the said chloropentafluoroethane (CFC-115); and a process B, in which a reaction mixture produced by the preceding reaction is separated into a first mixture (3) composed mainly of hydrogen and a second mixture (2), composed mainly of pentafluoroethane (HFC-125). In this method, purification is performed by adding the said first mixture (3) to the said unpurified mixture (1) in a state that the hydrogen chloride is removed from the first mixture (3) in process B until the level of hydrogen chloride drops to 0.5 or less than that of CFC-115 in the unpurified mixture (1) in the molar ratio, or hydrogen chloride is removed from the said reaction mixture until, when mixed with the unpurified mixture (1), the level of hydrogen chloride drops to 0.5 or less than that of CFC-115 in the mixture in the molar ratio. Thus, CFC-115 can be exterminated (or removed) cheaply and efficiently without decreasing it's reactivity (or activity) and a high yield of HFC-125 can be obtained. <IMAGE>
Patent DE-69517999-D1 (DE)
Inventor: RELLO M
IPC: B65C9/18
Filed: 1995-11-20
Granted: 2000-08-17
Abstract: A method and apparatus is disclosed for applying a label onto a substantially cylindrical article. The label drum (32) defines an article wrapping position. A thin layer, heat activated adhesive backed label (5) is fed onto a label receiving position of the drum. The label receiving positions of the drum are formed of a substantially smooth, resilient material, such as silicon. The label drum is rotated to move the label retained thereon into the article wrapping position. As the label is moved, the adhesive is heated so that the adhesive obtains a sufficient temperature to melt. A jet of air is blown onto the resilient surface for cooling the surface during subsequent label applying and ensuring rapid cooling of melted adhesive during labeling.
Patent DE-69524654-D1 (DE)
Inventor: HULBERT ANTHONY PETER
IPC: H04B1/707
Filed: 1995-01-30
Granted: 2002-01-31
Abstract: The cellular mobile radio system comprising at least two base stations, and at least one mobile unit arranged to communicate with the base stations via a radio medium. Each base station includes means for detecting the power of received signals, means for generating a power control signalling bit for controlling the amplitude of a power signal, and means for transmitting the power signal to the mobile unit. The mobile unit includes means for receiving the power control bits, and means for monitoring the power control bits to identify the base station sending a greater number of control bits over a transmit frame, indicating that that base station has received the higher average power signal over the transmit frame.   <IMAGE>
Patent DE-69526103-D1 (DE)
Inventor: HALL JOY
IPC: A61K31/16
Filed: 1995-07-21
Granted: 2002-05-02
Abstract: The present invention relates to compositions for treating acne and other skin lesions and also to methods of treatment utilizing these compositions. These compositions and methods of treatment employ benzoyl peroxide, a compound for reducing the skin irritation associated therewith, and a topical carrier.
Patent DE-69531943-D1 (DE)
Inventor: HART D
IPC: A61B19/00
Filed: 1995-05-26
Granted: 2003-11-20
Abstract: A suture locking button is described. The device includes a base element with a first axial passage for receiving at least one, and preferably two, suture filaments that is attached via a frangible membrane to a locking dement. The locking dement is adapted for movement from a first position, where the locking element extends outwardly from the base dement, to a second position, where the locking element is disposed within the base element by disrupting the frangible membrane to trap the suture filament(s) within the first axial passage between the locking element and the base element. The locking element may have a flange integral with its proximal end that effectively prevents the base element from backing out of the tissue in a direction proximal to the tissue. The invention also pertains to the combination of a suture and a device for securing the suture to a tissue. A method for securing tissue by way of a suture is also included within the scope of the invention.
Patent DE-69601491-D1 (DE)
Inventor: BROWN STEPHEN
IPC: C07C315/04
Filed: 1996-01-16
Granted: 1999-03-18
Abstract: PCT No. PCT/GB96/00081 Sec. 371 Date Jun. 24, 1997 Sec. 102(e) Date Jun. 24, 1997 PCT Filed Jan. 16, 1996 PCT Pub. No. WO96/22957 PCT Pub. Date Aug. 1, 1996A process for preparing a compound of formula (I), where R1, R2, R3, R4, R5 and R6 are independently hydrogen or C1-6 alkyl; R7 is halogen, cyano, NO2, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy or RaS in which Ra is C1-4 alkyl; R8, R9 and R10 independently are hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, CN, NO2, phenoxy or substituted phenoxy; RbS(O)n Om in which m is 0 or 1, n is 0, 1 or 2 and Rb is C1-4 alkyl, C1-4 haloalkyl, phenyl or benzyl, NHCORc in which c is C1-4 alkyl, NRdRe in which Rd and Re independently are hydrogen or C1-4 alkyl; RfC(O)- in which Rf is hydrogen, C1-4 alkyl, C1-4 haloalkyl or C1-4 alkoxy; SO2NRgRh in which Rg and Rh independently are hydrogen or C1-4 alkyl; or any two of R8, R9 and R10 together with the carbon atoms to which they are attached form a 5 or 6 membered heterocyclic ring containing up to three heteroatoms selected from 0, N or S and which may be optionally substituted by C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, =NOC1-4 alkyl, or halogen; which process comprises the rearrangement of a compound of formula (II), where R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined in relation to formula (I), in the presence of a base and a polar aprotic solvent characterized in that the process is carried out in a reaction medium substantially free of hydrogen cyanide or cyanide anion.    <IMAGE>  (I)   <IMAGE>  (II)
Patent DE-69616871-D1 (DE)
Inventor: WELVAARTS PETRUS WILHELMUS MAR
IPC: G01G21/18
Filed: 1996-05-23
Granted: 2001-12-20
Abstract: The invention relates to a weighing device for weighing loads. The weighing device comprises at least one pressure force indicator, which is connected to a frame, and an auxiliary frame, on which the load to be weighed is placed. A pressure force-transmitting means is provided between the pressure force indicator and the auxiliary frame, which pressure force-transmitting means is confined between two supporting surfaces. One supporting surface is connected to the pressure force indicator and the other is connected to the auxiliary frame. The parts of the weighing device supporting the supporting surfaces are interconnected by a connecting piece consisting of a resilient material. <IMAGE>
Patent DE-69620473-D1 (DE)
Inventor: TIROSH OREN
IPC: C07F9/10
Filed: 1996-12-10
Granted: 2002-05-08
Abstract: Ether-linked phospholipids, derivatized at the polar head group with polyethylene glycol chains having molecular weights greater than 2,000 daltons, are disclosed. Lipid bilayers containing these phospholipids show high oxidative stability. Also disclosed is the use of PEG-derivatized ether-linked lipids in moisturizing and radiation-protective cosmetic compositions.
Patent DE-69620898-D1 (DE)
Inventor: HOFFMAN S
IPC: A61K47/48
Filed: 1996-08-30
Granted: 2002-05-29
Abstract: The combination of the capabilities of stimuli-responsive components such as polymers and interactive molecules to form site-specific conjugates which are useful in a variety of assays, separations, processing, and other uses is disclosed. The polymer chain conformation and volume can be manipulated through alteration in pH, temperature, light, or other stimuli. The interactive molecules can be biomolecules like proteins or peptides, such as antibodies, receptors, or enzymes, polysaccharides or glycoproteins which specifically bind to ligands, or nucleic acids such as antisense, ribozymes, and aptamers, or ligands for organic or inorganic molecules in the environment or manufacturing processes. The stimuli-responsive polymers are coupled to the recognition biomolecules at a specific site so that the polymer can be manipulated by stimulation to alter ligand-biomolecule binding at an adjacent binding site, for example, the biotin binding site of streptavidin, the antigen-binding site of an antibody or the active, substrate-binding site of an enzyme. Binding may be completely blocked (i.e., the conjugate acts as an on-off switch) or partially blocked (i.e., the conjugate acts as a rheostat to partially block binding or to block binding only of larger ligands). Once a ligand is bound, it may also be ejected from the binding site by stimulating one (or more) conjugated polymers to cause ejection of the ligand and whatever is attached to it. Alternatively, selective partitioning, phase separation or precipitation of the polymer-conjugated biomolecule can be achieved through exposure of the stimulus-responsive component to an appropriate environmental stimulus.
Patent DE-69626218-D1 (DE)
Inventor: TUCKER A
IPC: C07D413/12
Filed: 1996-12-09
Granted: 2003-03-20
Abstract: This invention provides a novel oxazolidinone derivative represented by Formula I or pharmaceutical acceptable salts thereof:    <IMAGE>  I  wherein R1 is substituted or unsubstituted 2-pyrimidinyl, 4-pyrimidinyl, or 3-pyridazinyl; X is hydrogen or fluoro; R3 is C1-4 alkyl, C1-4 alkoxy, C3-6 cycloalkyl or C1-4 alkylamino or dialkylamino. The compounds are useful antimicrobial agents.
Patent DE-69633940-D1 (DE)
Inventor: O'NEILL KENNETH
IPC: C12Q1/6886
Filed: 1996-09-05
Granted: 2004-12-30
Abstract: The invention provides a method of isolating cells from a faecal stool, the method comprising the steps of a) cooling the stool to a temperature below its gel freezing point, and b) removing cells from the stool whilst maintaining the stool at a temperature below its gel freezing point such that the stool remains substantially intact. The invention further provides methods of purifying cells comprising use of immunomagnetic beads and/or boric acid. Cells isolated according to the invention may be used in diagnostic tests and assay procedures for monitoring a biological or biochemical property of tissue.
Patent DE-69635305-D1 (DE)
Inventor: LEVITT CLIFFORD
IPC: C12N5/10
Filed: 1996-08-23
Granted: 2006-03-02
Abstract: The present invention relates to the use of an antibody, which is an anti-interleukin-9 antibody or an anti-interleukin-9 receptor antibody, that blocks interleukin-9 binding to the interleukin-9 receptor, for the preparation of a medicament for the reduction of bronchial hyper-responsiveness in a patient.
Patent DE-69637589-D1 (DE)
Inventor: ALPINS NOEL AMI
IPC: A61F9/013
Filed: 1996-05-03
Granted: 2008-08-21
Abstract: A method of surgically treating an eye of a patient to correct astigmatism in which values of astigmatism are measured topographically and refractively, and limit values of targeted induced astigmatism for the topographically and refractively measured astigmatism values are obtained by summating the topographically value of astigmatism with the refractive value of astigmatism and vice versa. Respective target values of astigmatism for refraction and topography based on the limit values are obtained and surgical treatment is effected with a target induced astigmatism which is intermediate the limit values and provided respective topographical and refractive non-zero target astigmatism values whose sum is a minimum.
Patent DE-69700401-D1 (DE)
Inventor: BOTTING GREGORY J
IPC: A47L9/00
Filed: 1997-10-15
Granted: 1999-09-16
Abstract: A new platform (11) (sometimes referred to as a "caddy") for transporting a carpet cleaning machine (10) includes a base (39) for supporting the machine (10) and a machine restraint mechanism (53) for releasably coupling the machine (10) and the platform (11) to one another. The platform (11) also has wheels (49) (or an elongated roller-like wheel) mounted with respect to the base (39) for rolling the base (39) and the machine (10) across a surface . The restraint mechanism (53) has features preventing relative platform-machine movement along a single axis (61) or, when the mechanism includes pairs of two different types of restraining members (57a,b, 59a, b), along plural axes. <IMAGE>
Patent DE-69704687-D1 (DE)
Inventor: GODIN BRUNO
IPC: B60D1/00
Filed: 1997-03-12
Granted: 2001-06-07
Abstract: The trolley assembly consists of four or more trolleys (2) in pairs, mounted on wheels. Each trolley has front (16,18) and rear (20) coupling elements which can be connected by a towbar or plate (27), allowing one pair of trolleys to pivot relative to the other. On each trolley the coupling elements project from their front and rear faces. Each trolley has recesses (24,26,28) which allow the coupling elements on one trolley or pair of trolleys to engage with the recesses on another and take up less space. In a variant of the design the towbar can have four separate arms with pins to engage with lugs on the rear end of one pair of trolleys and the front end of the other pair.
Patent DE-69707372-D1 (DE)
Inventor: OGATA KAZUMI
IPC: A61K31/665
Filed: 1997-07-29
Granted: 2001-11-22
Abstract: The present invention provides a pharmaceutical composition for the therapy of acne vulgaris which comprises a phosphoric diester compound of the following formula or a pharmacologically acceptable salt thereof <CHEM> wherein R1 and R2 may be the same or different and each represents hydrogen or methyl.
Patent DE-69711422-D1 (DE)
Inventor: HARDING DEBORAH PHYLLIS
IPC: A61P9/00
Filed: 1997-08-06
Granted: 2002-05-02
Abstract: (R)-verapamil, or a pharmaceutically-acceptable salt thereof, is useful in the treatment of angina.
Patent DE-69712351-D1 (DE)
Inventor: TAYLOR RICHARD JOHN KENNETH
IPC: A61P17/00
Filed: 1997-09-05
Granted: 2002-06-06
Abstract: Compounds of the formula wherein R1 is a fucose or mannose residue, have therapeutic utility via inhibition of selectins, and thus of cell adhesion.
Patent DE-69720562-D1 (DE)
Inventor: BURGESS WALTER
IPC: D07B5/10
Filed: 1997-01-09
Granted: 2003-05-15
Abstract: The present invention is concerned with a compacted substantially triangular strand suitable for making wire ropes therefrom. The method for producing the novel compacted substantially triangular strand is also disclosed. The method includes covering a substantially triangular central group (10) with a first layer of from 7-12 wires (17), followed by the covering of the thus obtained strand with a second layer of from 10-15 wires (21) before passing the strand through a rotating substantially triangular die (24) to provide a compacted substantially triangular strand. <IMAGE>
Patent DE-69727671-D1 (DE)
Inventor: MOY DAVID
IPC: C01B31/02
Filed: 1997-05-15
Granted: 2004-03-25
Abstract: This invention relates to rigid porous carbon structures and to methods of making same. The rigid porous structures have a high surface area which are substantially free of micropores. Methods for improving the rigidity of the carbon structures include causing the nanofibers to form bonds or become glued with other nanofibers at the fiber intersections. The bonding can be induced by chemical modification of the surface of the nanofibers to promote bonding, by adding "gluing" agents and/or by pyrolyzing the nanofibers to cause fusion or bonding at the interconnect points.
Patent DE-69734683-D1 (DE)
Inventor: VINOGRADOV A
IPC: G01N21/64
Filed: 1997-12-12
Granted: 2005-12-22
Abstract: This invention relates to phosphorescent probes effective for oxygen measurement in human or animal tissue comprising a porphyrin chromophore capable of releasing absorbed energy as phosphorescent light and a dendrimer, wherein said porphyrin chromophore comprises the core of the dendrimer.
Patent DE-69734716-D1 (DE)
Inventor: WALSH LEO
IPC: A23L33/00
Filed: 1997-08-14
Granted: 2005-12-29
Abstract: A process for producing a nutrient supplement powder is provided. The process forms a powder into a plastic mass which is not completely molten. The plastic mass is then formed into an elongated shape and allowed to cool to set to a solid state. The solid is then comminuted to obtain a powder having a desirable particle size, e.g. not more than 5% by weight through a 120-mesh sieve and not more than 5% by weight retained on a 14-mesh sieve.
Patent DE-69805607-D1 (DE)
Inventor: CAMBOT-COURRAU YVES
IPC: F16L33/22
Filed: 1998-12-08
Granted: 2002-07-04
Abstract: PCT No. PCT/FR98/02654 Sec. 371 Date Jun. 28, 1999 Sec. 102(e) Date Jun. 28, 1999 PCT Filed Dec. 8, 1998 PCT Pub. No. WO99/30071 PCT Pub. Date Jun. 17, 1999The invention relates to a quick-coupling device for coupling a tube to a rigid element (50) having a bore, the device comprising a tubular insert (1) having means (7) enabling it to be anchored in the bore of the rigid element (50), declutchable tube retaining means (11), and a slide (13) mounted to move in translation in the tubular insert (1) to declutch the retaining means (11) when it is pushed into the tubular insert (1). The declutching slide (13) possesses a rear portion which projects outside the tubular insert (1) and which presents a shoulder surface (23) situated facing an end surface (24) of the tubular insert (1) and co-operating with said end surface to define a groove in which a removable intermediate ring (25) is received to oppose pushing in of the declutching slide (13).
Patent DE-69807349-D1 (DE)
Inventor: KUN ERNEST
IPC: A61K31/12
Filed: 1998-10-23
Granted: 2002-09-26
Abstract: The present invention provides methods for treating cancer, particularly malignant tumors, with ketone thyroxine analogues having no significant hormonal activity. A ketone thyroxine analogue is administered to an afflicted mammal in an amount effective to cause depression or regression of malignant tumor growth or to treat cancer. Particularly preferred ketone thyroxine analogues are those capable of causing about 35 percent or more inhibition of initial velocity of microtubule protein assembly in vitro.
Patent DE-69813649-D1 (DE)
Inventor: VERRA YVAN
IPC: E01F13/00
Filed: 1998-02-09
Granted: 2003-05-28
Abstract: The bollard consists of a housing (1) which surrounds the bollard (2) itself and contains a cover with a sleeve (4) for the bollard to slide in. The cover is removable for maintenance purposes. The housing contains a rotary lock (5) which lies parallel to the sleeve and is equipped with a lateral projection (8) which engages with ribs (9,10) projecting from the sleeve to prevent any unauthorised removal of the cover. The lock has a polygonal top (19) which can be turned by a special tool after sliding open a spring-loaded cover (18).
Patent DE-69830341-D1 (DE)
Inventor: BAUMAN JOHN G
IPC: C07D241/04
Filed: 1998-06-11
Granted: 2005-06-30
Abstract: This invention is directed to acyl piperazine derivatives which are useful as anti-inflammatory agents. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat inflammatory disorders in humans.
Patent DE-69831398-D1 (DE)
Inventor: CETNAR ROMAN
IPC: E05B65/20
Filed: 1998-02-04
Granted: 2005-10-06
Abstract: A power-operated vehicle door locking assembly including separate inner and outer door locking mechanisms connected with a housing assembly and an electric motorized system operable to selectively move (1) the inner door locking mechanism between an inoperative and an inner door locking position in response to inner manual electric motor energizing actuations and (2) the outer door locking mechanism between an inoperative and an outer door locking positions in response to outer manual electric motor energizing actuations. The arrangement is such that an outer manual electric motor energizing actuation without a corresponding inner manual electric motor energizing actuation causes a door latching assembly when in a door latching position to be incapable of being moved into a door unlatching position by an outer door latch releasing mechanism while at the same time the door latching assembly is capable of being moved into the door unlatching position thereof by an inner door latch releasing mechanism.